Loading clinical trials...
Loading clinical trials...
Addressing Disparities in Diabetes Care: Integrating Continuous Glucose Monitors and Pharmacist Medication Management for Uninsured Racial Minority Patients
The purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
The objective of this research is to determine the effectiveness of a targeted intervention that integrates continuous glucose monitors and pharmacist-led comprehensive medication management services among uninsured adult patients with poor glycemic control on basal insulin, specifically focusing on Black and Hispanic populations. This pilot study is designed to help justify implementing this intervention on a larger scale within our healthcare system.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Atrium Health Myers Park Internal Medicine Clinic
Charlotte, North Carolina, United States
Start Date
November 18, 2024
Primary Completion Date
August 12, 2025
Completion Date
September 22, 2025
Last Updated
November 3, 2025
20
ACTUAL participants
Continuous Glucose Monitor
BEHAVIORAL
Usual Care
BEHAVIORAL
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
NCT06959901
NCT06574035
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06861062